Lamivudine Stavudine & Nevirapine Tablets bulk supplier for pharma manufacturers

Lamivudine Stavudine & Nevirapine Tablets 150mg + 30mg + 200mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 150mg + 30mg + 200mg

Reference Brands: Generic formulations marketed under different names

Lamivudine Stavudine & Nevirapine Tablet is a medicine that is used for the treatment of Hiv Infection, Hepatitis B Virus Infection, Hiv-1 Infection and other conditions. Lamivudine Stavudine & Nevirapine Tablet contains Lamivudine, Nevirapine, and Satvudine as active ingredients. Lamivudine Stavudine & Nevirapine Tablet works by increasing the number of infection fighting cells in the body; blocking the activity of HIV-1 reverse transcriptase; stopping the reverse transcriptase from working, thus helps to control HIV-1 infection

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Lamivudine Stavudine & Nevirapine Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms: · Hiv Infection · Hepatitis B Virus Infection · Hiv-1 Infection Lamivudine Stavudine & Nevirapine Tablet Working, Mechanism of Action and Pharmacology Lamivudine Stavudine & Nevirapine Tablet improves the patient's condition by performing the following functions: · Increasing the number of infection fighting cells in the body. · Blocking the activity of HIV-1 reverse transcriptase. · Stopping the reverse transcriptase from working, thus helps to control HIV-1 infection.

Lamivudine Stavudine & Nevirapine Tablets — third party manufacturing & bulk supply

Lamivudine Stavudine & Nevirapine Tablets 150mg + 30mg + 200mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Lamivudine Stavudine & Nevirapine Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Lamivudine Stavudine & Nevirapine Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Lamivudine Stavudine & Nevirapine Tablet... →

Back to Listing

Frequently Asked Questions

Lamivudine, Stavudine, and Nevirapine are used together as a fixed-dose combination for the treatment of HIV-1 infection. This combination helps lower the viral load, improve immune function, and slow disease progression as part of antiretroviral therapy.

It is made from the active pharmaceutical ingredients lamivudine, stavudine, and nevirapine. These three antiretroviral agents belong to nucleoside reverse transcriptase inhibitors (lamivudine and stavudine) and a non-nucleoside reverse transcriptase inhibitor (nevirapine).

Common trade names include Triomune and several other regional fixed-dose combination brands.

Triomune was originally manufactured by Cipla, and various other approved pharmaceutical companies in India and other countries also manufacture this combination in generic form.

The generic name is lamivudine + stavudine + nevirapine fixed-dose combination.

Brand names include Triomune and multiple other generic brands depending on the manufacturer.

This combination is commonly manufactured in India by several WHO-approved and GMP-certified pharmaceutical companies, and also in other regions depending on regulatory approvals.